AlphaFold predicted structure
MYRF · Q9Y2G1

Mean pLDDT
60.4/ 100
Low
1,151 residues
Confidence breakdown
- Very high(≥ 90)27%
- Confident(70–90)16%
- Low(50–70)6%
- Very low(< 50)51%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
myelin regulatory factor
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Anophthalmia or microphthalmia
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownDDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownDifferences in sex development
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownStructural eye disease
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownCardiac-urogenital syndrome
encephalitis/encephalopathy, mild, with reversible myelin vacuolization
hyperopia, high
hereditary disease
microphthalmia
nanophthalmia
disorder of sexual differentiation
Abnormal heart morphology
urogenital tract malformation
disease of genitourinary system
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Myelin regulatory factor
Constitutes a precursor of the transcription factor. Mediates the autocatalytic cleavage that releases the Myelin regulatory factor, N-terminal component that specifically activates transcription of central nervous system (CNS) myelin genes (PubMed:23966832)
MYRF · Q9Y2G1

Mean pLDDT
60.4/ 100
Low
1,151 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0